All filters
Slidesets
Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Eradication of HIV- Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Eradication of HIV- Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Living donor liver transplantation for hepatitis virus related liver diseases- Chao-Long Chen, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Prevention of recurrent hepatitis B after liver transplantation- Chung Mau Lo, BBS, JP, MBBS, MS, FRCS, FRACS, FACS, FHKAM (Surgery), FCSHK
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Elimination of viral hepatitis: Global perspective- Zhongdan Chen, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Treatment of CHB in China: Experience and evidence from real-world studies- Jidong Jia, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Non-viral liver diseases in China- Zhongping Duan, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
CHB treatment with Chinese medicine and NAs- Yongping Yang, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
CHB treatment with Chinese medicine and NAs- Yongping Yang, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Efficacy and tolerability of grazoprevir and elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV and HIV co-infection: A nonrandomised, open-label clinical trial- Chien-Yu Cheng
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
HIV-1/HCV co-infection treatment with single-tablet antiviral regimens (CoSTARs): 12 Weeks of Ledipasvir/ Sofosbuvir (LDV/SOF) after randomized switch to Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir alafenamide (E/C/F/TAF) or rilpivirin- Damian Mccoll
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
New indicators for the evaluation of hepatitis B therapy- Xinxin Zhang, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Sequential cross-section study on hepatitis viruses infection in Chinese AIDS patients- Lin Liu, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Non-alcoholic fatty liver disease in China- Jiangao Fan, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Videos
Specific Complex Interactions (mechanic presentation) | David Burger, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Backing up clinical data with modelling | Marco Siccardi, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Back-terial co-infections | Mohammed Lamorde, FRCP, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
The ‘Back Side’ of Compartments | Saye Khoo, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Will we see the Back of DDIs? | Catia Marzolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Pharmacogenetics - Back to reality | Andrew Owen, BSS, MSC, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Looking Backwards: Hormonal Contraception and ART | Kimberly Scarsi, PharmD, MS, FCCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016